TAOM [Taomee] SC 13G: (Original Filing)
[Crow Zhen Wei Universys Holdings Ltd. EX-99.1 2 d294009dex991.htm JOINT FILING AGREEMENT] [1 NAME OF REPORTING PERSON Crow Zhen Wei 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ ¨ (a) 3]
[Crow Zhen Wei Universys Holdings Ltd. EX-99.1 2 d294009dex991.htm JOINT FILING AGREEMENT] [1 NAME OF REPORTING PERSON Crow Zhen Wei 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ ¨ (a) 3]
[] [Certification by the Chief Executive Officer I, Don Dongjie Yang, certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [Certification by the Chief Financial Officer I, Weiguo Ge, certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in Registration Statement No. 333-143267 on Form S-8 of our report dated April 27, 2011, relating to the consolidated financial statements and financial statement schedule of Acorn International, Inc and its subsidiaries and variable interest entities (collectively the Company), which report expresses an unqualified opinion]
[Benson Haibing Wang Joy Union Holdings Limited EX-99.1 2 d294005dex991.htm JOINT FILING AGREEMENT] [1 NAME OF REPORTING PERSON Benson Haibing Wang 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ ¨ (a)]
[CUSIP No.477374 102 1. Names of Reporting Persons 2. Check the Appropriate Box if a Member of a (See Instructions) (a) o (b) o 3. SEC Use Only 4. Citizenship or Place of Organization Number of 5. Sole Voting Power 6. Shared Voting Power 7. Sole Dispositive Power 8. Shared Dispositive Power] [Joint Filingreement Haiyan Gong Haiyan Gong Aprilsky Haiyan Gong Director EX-99.1 a12-4108_3ex99d1.htm 2 EX-99.1]
[American Lorain Corporation February 6, 2012 Re: American Lorain Corporation Form 10-K for Fiscal Year Ended December 31, 2010 Dear Mr. Skinner: On behalf of American Lorain Corporation (we or the Company), we respond as follows to the Staffs comment letter dated December 21, 2011 relating to the above-captioned annual report on Form 10-K. Please note that for the Staffs]
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts:]
[SCHEDULE 13G CUSIP No. 09777B107 Page 2 of 12 Pages (1) Names of reporting persons SEQUOIA CAPITAL CHINA I, L.P. (SCC I) I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) 20-3514012 (2)]
[Sze Kit Ting 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o b) o 3 SEC USE ONLY 4 SOURCE OF FUNDS 5 o 6 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF 7 2,860,000 Shares SOLE VOTING POWER 8 0 Shares SHARED VOTING POWER 9 2,860,000 Shares SOLE DISPOSITIVE POWER 10 0 Shares SHARED DISPOSITIVE POWER]
[Brightest Power Holdings Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ x (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER (1) 15,900,000 ordinary shares 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER (1) 15,900,000 ordinary shares 8 SHARED]
[Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement Press Release: Sinovac Biotech Co., Ltd. – Tue, Jan 24, 2012 4:05 PM EST BEIJING, Jan. 24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based] [Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease Press Release: Sinovac Biotech Ltd. – Tue, Jan 10, 2012 8:00 AM EST BEIJING , Jan. 10, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of biopharmaceutical products in China , announced today that the phase III clinical] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]